IS4029A - DNA-raðir notaðar við framleiðslu á endurröðuðum mennskum gallsaltahvötuðum lípasa - Google Patents

DNA-raðir notaðar við framleiðslu á endurröðuðum mennskum gallsaltahvötuðum lípasa

Info

Publication number: IS4029A
Authority: IS; Iceland
Prior art keywords: production; dna sequences; recombinant human; sequences used; bile salt
Prior art date: 1992-06-11

Application number

IS4029A

Other languages

English (en)

Inventor

Gunnar Bjursell Karl

Nils Ivar Carlsson Peter

Sven Magnus Enerbäck Curt

Lennart Hansson Stig

Fredrik Pontus Lidberg Ulf

Annika Nilsson Jeanette

Birger Fredrik Törnell Jan

Original Assignee

Ab Astra

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-11

Filing date

1993-06-07

Publication date

1993-12-12

1992-06-11 Priority claimed from SE9201809A external-priority patent/SE9201809D0/xx

1992-06-12 Priority claimed from SE9201826A external-priority patent/SE9201826D0/xx

1992-07-03 Priority claimed from SE9202088A external-priority patent/SE9202088D0/xx

1993-03-19 Priority claimed from SE9300902A external-priority patent/SE9300902D0/xx

1993-06-07 Application filed by Ab Astra filed Critical Ab Astra

1993-12-12 Publication of IS4029A publication Critical patent/IS4029A/is

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Environmental Sciences (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Animal Husbandry (AREA)
Plant Pathology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biodiversity & Conservation Biology (AREA)
Animal Behavior & Ethology (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Medicinal Chemistry (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)

IS4029A 1992-06-11 1993-06-07 DNA-raðir notaðar við framleiðslu á endurröðuðum mennskum gallsaltahvötuðum lípasa IS4029A (is)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
SE9201809A SE9201809D0 (sv)	1992-06-11	1992-06-11	New dna sequences
SE9201826A SE9201826D0 (sv)	1992-06-12	1992-06-12	New dna sequences ii
SE9202088A SE9202088D0 (sv)	1992-07-03	1992-07-03	New dna sequences iii
SE9300902A SE9300902D0 (sv)	1993-03-19	1993-03-19	New dna sequences iv

Publications (1)

Publication Number	Publication Date
IS4029A true IS4029A (is)	1993-12-12

Family

ID=27484751

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS4029A IS4029A (is)	1992-06-11	1993-06-07	DNA-raðir notaðar við framleiðslu á endurröðuðum mennskum gallsaltahvötuðum lípasa

Country Status (31)

Country	Link
US (2)	US5616483A (is)
EP (1)	EP0651793B1 (is)
JP (1)	JP4231105B2 (is)
KR (1)	KR100357670B1 (is)
CN (1)	CN1071791C (is)
AP (1)	AP411A (is)
AT (1)	ATE447012T1 (is)
AU (1)	AU670598B2 (is)
CA (1)	CA2137815C (is)
CZ (1)	CZ288677B6 (is)
DE (1)	DE69334298D1 (is)
DK (1)	DK0651793T3 (is)
ES (1)	ES2335626T3 (is)
FI (1)	FI945793A7 (is)
HR (1)	HRP930935A2 (is)
HU (1)	HU220338B (is)
IL (1)	IL105874A (is)
IS (1)	IS4029A (is)
MA (1)	MA22905A1 (is)
MX (1)	MX9303439A (is)
NO (1)	NO944715L (is)
NZ (1)	NZ253391A (is)
PH (1)	PH31680A (is)
PT (1)	PT651793E (is)
RU (1)	RU2128708C1 (is)
SG (1)	SG52580A1 (is)
SI (1)	SI9300319A (is)
SK (1)	SK286993B6 (is)
TN (1)	TNSN93067A1 (is)
UA (1)	UA41322C2 (is)
WO (1)	WO1993025669A1 (is)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ281041A (en) *	1994-03-09	1998-04-27	Abbott Lab	Non-human mammals transformed with a catalytic entity of enzymes or antibodies to produce a heterologous product in the animals milk
US5907080A (en) *	1995-11-30	1999-05-25	Nexia Biotechnologies, Inc.	Method for development of transgenic dwarf goats
ATE291080T1 (de)	1996-12-06	2005-04-15	Aventis Pharma Inc	Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
US7008776B1 (en) *	1996-12-06	2006-03-07	Aventis Pharmaceuticals Inc.	Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
FR2763958A1 (fr) *	1997-05-29	1998-12-04	Transgene Sa	Produit de combinaison associant un acide nucleique a une substance desorganisant la matrice extracellulaire pour la therapie genique
US20010006630A1 (en) *	1997-09-02	2001-07-05	Oron Yacoby-Zeevi	Introducing a biological material into a patient
US20040213789A1 (en) *	1997-09-02	2004-10-28	Oron Yacoby-Zeevi	Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US20020088019A1 (en) *	1997-09-02	2002-07-04	Oron Yacoby-Zeevi	Methods of and pharmaceutical compositions for improving implantation of embryos
US6177545B1 (en) *	1997-09-02	2001-01-23	Insight Strategy & Marketing Ltd.	Heparanase specific molecular probes and their use in research and medical applications
US6699672B1 (en)	1997-09-02	2004-03-02	Insight Biopharmaceuticals Ltd.	Heparanase specific molecular probes and their use research and medical applications
SE9801424D0 (sv) *	1998-04-22	1998-04-22	Astra Ab	Expression methods
US20030217375A1 (en) *	1998-08-31	2003-11-20	Eyal Zcharia	Transgenic animals expressing heparanase and uses thereof
EP1157118A4 (en) *	1999-03-01	2002-07-17	Insight Strategy & Marketing	POLYNUCLEOTID ENCODING A POLYPEPTIDE WITH HEPARANASE ACTIVITY AND ITS EXPRESSION IN GENETICALLY MODIFIED CELLS
AU4074400A (en) *	1999-04-09	2000-11-14	Human Genome Sciences, Inc.	49 human secreted proteins
AU5032600A (en) *	1999-05-19	2001-12-03	Barnes-Jewish Hospital	Enhanced triglyceride digestion in a deficiency of bile salts
US7402660B2 (en)	2000-08-02	2008-07-22	The Johns Hopkins University	Endothelial cell expression patterns
IT1319655B1 (it)	2000-11-15	2003-10-23	Eurand Int	Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US20020182243A1 (en) *	2001-05-14	2002-12-05	Medo Elena Maria	Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) *	2001-05-14	2010-10-21	Prolacta Bioscience	Method for collecting, testing and distributing milk
US6671189B2 (en) *	2001-11-09	2003-12-30	Minebea Co., Ltd.	Power converter having primary and secondary side switches
US20030213007A1 (en) *	2002-03-27	2003-11-13	Slattery Charles Wilbur	Human milk produced by human mammary tissue implanted in non-human host animals and uses thereof
US20060269552A1 (en) *	2003-06-09	2006-11-30	Oron Yacoby-Zeevi	Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
WO2007035870A2 (en) *	2005-09-20	2007-03-29	Prolacta Bioscience, Inc.	A method for testing milk
WO2007089133A1 (en) *	2006-02-03	2007-08-09	Academisch Medisch Centrum Bij De Universiteit Van Amsterdam	Means and methods for influencing interactions between dc-sign and dc-sign ligands
EP3485742B1 (en) *	2006-11-29	2021-09-01	Prolacta Bioscience, Inc.	Human milk compositions and methods of making and using same
WO2008073888A2 (en)	2006-12-08	2008-06-19	Prolacta Bioscience, Inc.	Compositions of human lipids and methods of making and using same
DK2079445T3 (en)	2007-02-20	2016-02-15	Allergan Pharmaceuticals Internat Ltd	Stable digestive compositions
WO2009109856A2 (en)	2008-03-07	2009-09-11	Axcan Pharma Inc.	Method for detecting infectious parvovirus in pharmaceutical preparations
US8927027B2 (en)	2008-12-02	2015-01-06	Prolacta Bioscience	Human milk permeate compositions and methods of making and using same
KR20140019292A (ko)	2010-10-01	2014-02-14	아프탈리스 파르마 리미티드	장용 코팅된 저 강도 췌장 리파제 제제
JP5800907B2 (ja)	2010-10-21	2015-10-28	スウェディッシュオーファンバイオビトラムパブリークアクチエボラグ	ヒト乳児による不飽和脂肪酸の吸収を増大させる方法
WO2012052060A1 (en) *	2010-10-21	2012-04-26	Swedish Orphan Biovitrum Ab (Publ)	Method to increase the growth velocity of human infants
ES2655019T3 (es)	2011-08-03	2018-02-16	Prolacta Bioscience, Inc.	Microfiltración de leche humana para reducir la contaminación bacteriana
ES2558756T3 (es)	2011-08-08	2016-02-08	Aptalis Pharma Limited	Método para la prueba de disolución de composiciones sólidas que contienen enzimas digestivas
CN103088000A (zh) *	2012-03-23	2013-05-08	北京济福霖生物技术有限公司	在哺乳动物乳腺中过表达胆盐激活脂酶的方法
US9605255B2 (en) *	2012-07-12	2017-03-28	Proqr Therapeutics Ii B.V.	Oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell
BR112015022059B1 (pt)	2013-03-13	2021-06-08	Prolacta Bioscience, Inc	composições de nata de leite humano pasteurizada com alto teor de gordura e método para fabricar uma composição de nata de leite humano pasteurizada com alto teor de gordura
US10184121B2 (en)	2013-06-28	2019-01-22	Allergan Pharmaceuticals International Limited	Methods for removing viral contaminants from pancreatic extracts
RU2679832C2 (ru)	2013-08-09	2019-02-13	Аллерган Фармасьютикалз Интернэйшнл Лимитед	Композиция пищеварительных ферментов, подходящая для энтерального введения
AU2016381834B2 (en)	2015-12-30	2021-09-23	Prolacta Bioscience, Inc.	Human milk products useful in pre- and post-operative care
KR20220066904A (ko)	2019-09-24	2022-05-24	프롤랙타 바이오사이언스, 인코포레이티드	염증 및 면역 질환의 치료용 조성물 및 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3256150A (en) *	1964-04-20	1966-06-14	Dairyland Food Lab	Method for treating malabsorption syndrome
GB1509866A (en) *	1975-06-10	1978-05-04	Johnson & Johnson	Enteric coated digestive enzyme compositions
US4873316A (en) *	1987-06-23	1989-10-10	Biogen, Inc.	Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5200183A (en) *	1987-11-19	1993-04-06	Oklahoma Medical Research Foundation	Recombinant bile salt activated lipases
US4944944A (en) *	1987-11-19	1990-07-31	Oklahoma Medical Research Foundation	Dietary compositions and methods using bile salt-activated lipase
SU1573026A1 (ru) *	1988-07-22	1990-06-23	Институт Биохимии И Физиологии Микроорганизмов Ан Ссср	Рекомбинантна плазмидна ДНК pBG М3, определ юща синтез эндонуклеазы рестрикции С @ BI
US5173408A (en) *	1989-11-13	1992-12-22	Lange Louis George Iii	Mammalian pancreatic cholesterol esterase
WO1991015534A1 (en) *	1990-03-30	1991-10-17	Allied-Signal Inc.	Electrically conductive poly(aromatic vinylenes) and poly(heteroaromatic vinylenes)
SE9001985D0 (sv) *	1990-06-01	1990-06-01	Astra Ab	New chemical products

1993
- 1993-05-27 US US08/068,945 patent/US5616483A/en not_active Expired - Lifetime
- 1993-05-27 HR HR930935A patent/HRP930935A2/hr not_active Application Discontinuation
- 1993-06-01 IL IL10587493A patent/IL105874A/en not_active IP Right Cessation
- 1993-06-07 IS IS4029A patent/IS4029A/is unknown
- 1993-06-09 WO PCT/SE1993/000515 patent/WO1993025669A1/en not_active Ceased
- 1993-06-09 PT PT93913744T patent/PT651793E/pt unknown
- 1993-06-09 EP EP93913744A patent/EP0651793B1/en not_active Expired - Lifetime
- 1993-06-09 MA MA23204A patent/MA22905A1/fr unknown
- 1993-06-09 KR KR1019940704513A patent/KR100357670B1/ko not_active Expired - Lifetime
- 1993-06-09 AT AT93913744T patent/ATE447012T1/de active
- 1993-06-09 DK DK93913744.4T patent/DK0651793T3/da active
- 1993-06-09 ES ES93913744T patent/ES2335626T3/es not_active Expired - Lifetime
- 1993-06-09 FI FI945793A patent/FI945793A7/fi unknown
- 1993-06-09 JP JP50138694A patent/JP4231105B2/ja not_active Expired - Lifetime
- 1993-06-09 MX MX9303439A patent/MX9303439A/es unknown
- 1993-06-09 SG SG1996006322A patent/SG52580A1/en unknown
- 1993-06-09 RU RU94046360/13A patent/RU2128708C1/ru active
- 1993-06-09 DE DE69334298T patent/DE69334298D1/de not_active Expired - Lifetime
- 1993-06-09 AU AU43667/93A patent/AU670598B2/en not_active Expired
- 1993-06-09 NZ NZ253391A patent/NZ253391A/en not_active IP Right Cessation
- 1993-06-09 UA UA94129155A patent/UA41322C2/uk unknown
- 1993-06-09 CA CA2137815A patent/CA2137815C/en not_active Expired - Lifetime
- 1993-06-09 PH PH46323A patent/PH31680A/en unknown
- 1993-06-09 CZ CZ19943091A patent/CZ288677B6/cs not_active IP Right Cessation
- 1993-06-09 HU HU9403536A patent/HU220338B/hu unknown
- 1993-06-09 SK SK1486-94A patent/SK286993B6/sk not_active IP Right Cessation
- 1993-06-10 AP APAP/P/1993/000538A patent/AP411A/en active
- 1993-06-11 CN CN93108717A patent/CN1071791C/zh not_active Expired - Lifetime
- 1993-06-11 SI SI9300319A patent/SI9300319A/sl not_active IP Right Cessation
- 1993-06-11 TN TNTNSN93067A patent/TNSN93067A1/fr unknown
1994
- 1994-12-07 NO NO944715A patent/NO944715L/no not_active Application Discontinuation
1995
- 1995-05-17 US US08/442,806 patent/US5716817A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JPH07507687A (ja)	1995-08-31
IL105874A0 (en)	1993-10-20
ATE447012T1 (de)	2009-11-15
HU220338B (hu)	2001-12-28
EP0651793A1 (en)	1995-05-10
US5616483A (en)	1997-04-01
HU9403536D0 (en)	1995-02-28
HUT71789A (en)	1996-02-28
RU94046360A (ru)	1997-06-10
ES2335626T3 (es)	2010-03-30
FI945793L (fi)	1995-02-09
FI945793A7 (fi)	1995-02-09
CZ309194A3 (en)	1995-07-12
CA2137815A1 (en)	1993-12-23
WO1993025669A1 (en)	1993-12-23
AU4366793A (en)	1994-01-04
SG52580A1 (en)	1998-09-28
SI9300319A (en)	1994-03-31
AP9300538A0 (en)	1993-07-31
DK0651793T3 (da)	2010-03-15
TNSN93067A1 (fr)	1994-03-17
EP0651793B1 (en)	2009-10-28
SK148694A3 (en)	1995-08-09
KR100357670B1 (ko)	2003-04-11
IL105874A (en)	1998-12-27
FI945793A0 (fi)	1994-12-09
UA41322C2 (uk)	2001-09-17
CN1086262A (zh)	1994-05-04
NZ253391A (en)	1996-01-26
CA2137815C (en)	2010-11-09
NO944715D0 (no)	1994-12-07
CN1071791C (zh)	2001-09-26
HRP930935A2 (en)	1994-12-31
CZ288677B6 (cs)	2001-08-15
JP4231105B2 (ja)	2009-02-25
US5716817A (en)	1998-02-10
MX9303439A (es)	1994-04-29
PT651793E (pt)	2010-01-20
NO944715L (no)	1995-02-07
SK286993B6 (sk)	2009-09-07
RU2128708C1 (ru)	1999-04-10
AP411A (en)	1995-09-28
DE69334298D1 (de)	2009-12-10
AU670598B2 (en)	1996-07-25
MA22905A1 (fr)	1993-12-31
PH31680A (en)	1999-01-18

Publication	Publication Date	Title
IS4029A (is)	1993-12-12	DNA-raðir notaðar við framleiðslu á endurröðuðum mennskum gallsaltahvötuðum lípasa
FI953838L (fi)	1995-09-06	Imidatsopyriidineja ja niiden käyttö maha-suolisairauksien hoidossa
FI960469A7 (fi)	1996-03-27	DNA:ta sekvenssoivia entsyymejä
DE69637065D1 (de)	2007-06-14	Die bestimmung von nukleinsäuren und nukleinsäure-einheiten
DE69535031D1 (de)	2006-07-20	Selektive Acylierung von Epsilon-Aminogruppen in Insulin
DE68917729D1 (de)	1994-09-29	Reinigung und verabreichung von dns-reparatur-enzymen.
IT1225148B (it)	1990-11-02	Liberazione prolungata e controllata di peptidi insolubili in acqua
FI961438L (fi)	1996-03-29	beta-amyloidiproteiinituotannon estäjiä
DE69431719D1 (de)	2002-12-19	Hybridisierung und sequenzierung von nukleinsäuren
FI954966L (fi)	1995-10-18	Puutteellisia yhdistelmä-DNA-adenoviruksia kasvainten geeniterapiassa
PT88425A (pt)	1989-07-31	Dna sequences recombinant dna molecules and processes for producing soluble t4 proteins
DE69420284D1 (de)	1999-09-30	Percarbonsäuren
DE3882593D1 (de)	1993-09-02	Polypeptid und dessen herstellung.
NO991839D0 (no)	1999-04-16	FremgangsmÕter og preparater for utlevering og ekspresjon av interferon-<alfa>-nukleinsyrer
FI885024A7 (fi)	1989-05-03	Hyytymistä estävän proteiinin PP4 valmistus geeniteknologian avulla
EP0363436A4 (en)	1990-06-26	CLONED GENES OF PROTEIN G VERSIONS AND PROTEIN G VERSIONS EXPRESSED THEREOF.
DE3585890D1 (de)	1992-05-27	Peptid und dafuer kodierendes gen.
NO905561D0 (no)	1990-12-21	Proteiner og nukleinsyrer.
IS4033A (is)	1993-12-18	Hliðstæð aðferð til framleiðslu á isobenzofuranylafleiðum og milliefni til notkunar með aðferðinni
ZA918423B (en)	1993-04-22	Proteins and nucleic acids.
DE69213637D1 (de)	1996-10-17	Herstellung von 2-Hydroxymandelsäuren und 2-Hydroxybenzaldehyden
NO881502D0 (no)	1988-04-07	Rekombinante htlv-111 proteiner og anvendelse av disse.
FI885301A7 (fi)	1989-05-18	Tekijä VIII:n puhdistuksessa käyttökelpoisia peptidejä
DK75393D0 (da)	1993-06-24	Production of protein
FI944997L (fi)	1994-10-24	Parannettu rekombinantti-proteiinien tuotanto